Bionano genomics to present at the 32nd annual oppenheimer healthcare conference

San diego, march 08, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™, a leading software solution for visualization, interpretation, and reporting of genomic data, announced today that company management will present virtually at the 32nd annual oppenheimer healthcare conference. erik holmlin, phd, bionano's president and chief executive officer, is scheduled to present a corporate overview on tuesday, march 15th, 2022 at 5:40 am pt/8:40 am et.
BNGO Ratings Summary
BNGO Quant Ranking